While this principle has shown great promise in the research setting it has not yet come into routine use
Comparing GLP-1 treatment: weight loss vs muscle retention When it comes to weight loss and muscle mass, GLP-1 medications offer a unique advantage over traditional weight loss methods
Hoboken, New Jersey: John Wiley & Sons (2015)
PPAR: peroxisome proliferator-activated receptor alpha
Retatrutide is not yet licensed in the UK by the MHRA or EMA, and it is important to clarify that doses are measured in milligrams (mg), not 'units' as used for insulin
It can affect sleep, mood, memory, liver health, heart health, and mental health